Targeting IL-17B–IL-17RB signaling with an anti–IL-17RB antibody blocks pancreatic cancer metastasis by silencing multiple chemokines

Pancreatic cancer has an extremely high mortality rate due to its aggressive metastatic nature. Resolving the underlying mechanisms will be crucial for treatment. Here, we found that overexpression of IL-17B receptor (IL-17RB) strongly correlated with postoperative metastasis and inversely correlate...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Exp Med
Autors principals: Wu, Heng-Hsiung, Hwang-Verslues, Wendy W., Lee, Wen-Hsin, Huang, Chun-Kai, Wei, Pei-Chi, Chen, Chia-Lin, Shew, Jin-Yuh, Lee, Eva Y.-H.P., Jeng, Yung-Ming, Tien, Yu-Wen, Ma, Che, Lee, Wen-Hwa
Format: Artigo
Idioma:Inglês
Publicat: The Rockefeller University Press 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4354366/
https://ncbi.nlm.nih.gov/pubmed/25732306
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1084/jem.20141702
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars